Repair & Metabolic Stack Repair & Metabolic Stack STACK IMAGE
BATCH COA SUPPLIED HPLC VERIFIED RESEARCH USE ONLY
— STACK · 3 COMPOUNDS

Repair & Metabolic Stack Retatrutide + BPC-157 + TB-500

For in vitro research use only. Repair & Metabolic Stack is not for human or veterinary consumption, diagnosis, treatment, or prevention of any condition.

Research bundle pairing Retatrutide's triple-receptor metabolic pathway coverage (GLP-1, GIP, and glucagon) with the two most widely studied preclinical repair peptides. BPC-157 is investigated for tissue repair, angiogenesis, and mucosal protection; TB-500 for cellular migration and actin-mediated tissue organisation.

Research overview

Research bundle pairing Retatrutide's triple-receptor metabolic pathway coverage (GLP-1, GIP, and glucagon) with the two most widely studied preclinical repair peptides. BPC-157 is investigated for tissue repair, angiogenesis, and mucosal protection; TB-500 for cellular migration and actin-mediated tissue organisation. Allows researchers to study metabolic and tissue pathway interactions within a single protocol. Three individual lyophilised vials. For in vitro research use only.

Compounds in this stack

Retatrutide

GLP-1 / GIP / Glucagon Triple Agonist

A synthetic peptide that simultaneously activates three distinct metabolic receptors — GLP-1, GIP, and glucagon — each involved in regulating energy balance, insulin response, and fat metabolism. By engaging all three pathways at once, it offers researchers a tool for studying multi-receptor metabolic signalling in ways that single-agonist compounds cannot.

BPC-157

Body Protection Compound-157

A 15-amino-acid synthetic peptide that is among the most extensively studied repair-focused compounds in preclinical science. Rodent studies have investigated its role in stimulating new blood vessel formation (angiogenesis), accelerating wound tissue closure, and protecting the stomach and intestinal lining from experimentally induced damage.

CAS 137525-51-0 99.4% HPLC View BPC-157 →

TB-500

Thymosin Beta-4

A synthetic version of Thymosin Beta-4, a protein naturally present in mammalian tissue. Preclinical studies investigate its role in regulating actin — a structural protein that controls how cells move and organise during tissue repair.

CAS 77591-33-4 98.8% HPLC View TB-500 →

Compliance notice

For in vitro research use only. This stack is supplied solely as research reagents for qualified professionals conducting in vitro or animal-model studies. No compound in this stack is a medicinal product. None has been evaluated by the MHRA or FDA. None is intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition.

Compliance statement. Velox Peptides supplies research reagents for in vitro use by qualified researchers. Every compound is sold strictly as a research reagent. No product is a medicinal product within the meaning of the Human Medicines Regulations 2012. No product has been evaluated by the MHRA or FDA. No product is intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Any use outside lawful scientific research is outside the scope of sale. See our Research Use Policy and MHRA Statement.